Cargando…
Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models
OBJECTIVE: This study aimed to describe, optimize and evaluate a method for preparing multivalent conjugate vaccines by simultaneous conjugation of two different bacterial capsular polysaccharides (CPs) with tetanus toxoid (TT) as bivalent conjugates. METHODS: Different molecular weights (MWs) of po...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Huazhong University of Science and Technology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862236/ https://www.ncbi.nlm.nih.gov/pubmed/36680685 http://dx.doi.org/10.1007/s11596-022-2652-y |
_version_ | 1784875043049701376 |
---|---|
author | Huang, Fang Jing, Xiao-bing Li, Yin-bo Wang, Qian Liu, Si-li Yang, Zhi-rong Feng, Su |
author_facet | Huang, Fang Jing, Xiao-bing Li, Yin-bo Wang, Qian Liu, Si-li Yang, Zhi-rong Feng, Su |
author_sort | Huang, Fang |
collection | PubMed |
description | OBJECTIVE: This study aimed to describe, optimize and evaluate a method for preparing multivalent conjugate vaccines by simultaneous conjugation of two different bacterial capsular polysaccharides (CPs) with tetanus toxoid (TT) as bivalent conjugates. METHODS: Different molecular weights (MWs) of polysaccharides, activating agents and capsular polysaccharide/protein (CP/Pro) ratio that may influence conjugation and immunogenicity were investigated and optimized to prepare the bivalent conjugate bulk. Using the described method and optimized parameters, a 20-valent pneumococcal conjugate vaccine and a bivalent meningococcal vaccine were developed and their effectiveness was compared to that of corresponding licensed vaccines in rabbit or mouse models. RESULTS: The immunogenicity test revealed that polysaccharides with lower MWs were better for Pn1-TT-Pn3 and MenA-TT-MenC, while higher MWs were superior for Pn4-TT-Pn14, Pn6A-TT-Pn6B, Pn7F-TT-Pn23F and Pn8-TT-Pn11A. For activating polysaccharides, 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) was superior to cyanogen bromide (CNBr), but for Pn1, Pn3 and MenC, N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDAC) was the most suitable option. For Pn6A-TT-Pn6B and Pn8-TT-Pn11A, rabbits immunized with bivalent conjugates with lower CP/Pro ratios showed significantly stronger CP-specific antibody responses, while for Pn4-TT-Pn14, higher CP/Pro ratio was better. Instead of interfering with the respective immunological activity, our bivalent conjugates usually induced higher IgG titers than their monovalent counterparts. CONCLUSION: The result indicated that the described conjugation technique was feasible and efficacious to prepare glycoconjugate vaccines, laying a solid foundation for developing extended-valent multivalent or combined conjugate vaccines without potentially decreased immune function. |
format | Online Article Text |
id | pubmed-9862236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Huazhong University of Science and Technology |
record_format | MEDLINE/PubMed |
spelling | pubmed-98622362023-01-23 Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models Huang, Fang Jing, Xiao-bing Li, Yin-bo Wang, Qian Liu, Si-li Yang, Zhi-rong Feng, Su Curr Med Sci Article OBJECTIVE: This study aimed to describe, optimize and evaluate a method for preparing multivalent conjugate vaccines by simultaneous conjugation of two different bacterial capsular polysaccharides (CPs) with tetanus toxoid (TT) as bivalent conjugates. METHODS: Different molecular weights (MWs) of polysaccharides, activating agents and capsular polysaccharide/protein (CP/Pro) ratio that may influence conjugation and immunogenicity were investigated and optimized to prepare the bivalent conjugate bulk. Using the described method and optimized parameters, a 20-valent pneumococcal conjugate vaccine and a bivalent meningococcal vaccine were developed and their effectiveness was compared to that of corresponding licensed vaccines in rabbit or mouse models. RESULTS: The immunogenicity test revealed that polysaccharides with lower MWs were better for Pn1-TT-Pn3 and MenA-TT-MenC, while higher MWs were superior for Pn4-TT-Pn14, Pn6A-TT-Pn6B, Pn7F-TT-Pn23F and Pn8-TT-Pn11A. For activating polysaccharides, 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) was superior to cyanogen bromide (CNBr), but for Pn1, Pn3 and MenC, N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDAC) was the most suitable option. For Pn6A-TT-Pn6B and Pn8-TT-Pn11A, rabbits immunized with bivalent conjugates with lower CP/Pro ratios showed significantly stronger CP-specific antibody responses, while for Pn4-TT-Pn14, higher CP/Pro ratio was better. Instead of interfering with the respective immunological activity, our bivalent conjugates usually induced higher IgG titers than their monovalent counterparts. CONCLUSION: The result indicated that the described conjugation technique was feasible and efficacious to prepare glycoconjugate vaccines, laying a solid foundation for developing extended-valent multivalent or combined conjugate vaccines without potentially decreased immune function. Huazhong University of Science and Technology 2023-01-21 2023 /pmc/articles/PMC9862236/ /pubmed/36680685 http://dx.doi.org/10.1007/s11596-022-2652-y Text en © Huazhong University of Science and Technology 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Huang, Fang Jing, Xiao-bing Li, Yin-bo Wang, Qian Liu, Si-li Yang, Zhi-rong Feng, Su Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models |
title | Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models |
title_full | Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models |
title_fullStr | Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models |
title_full_unstemmed | Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models |
title_short | Optimization of the Process for Preparing Bivalent Polysaccharide Conjugates to Develop Multivalent Conjugate Vaccines against Streptococcus pneumoniae or Neisseria meningitidis and Comparison with the Corresponding Licensed Vaccines in Animal Models |
title_sort | optimization of the process for preparing bivalent polysaccharide conjugates to develop multivalent conjugate vaccines against streptococcus pneumoniae or neisseria meningitidis and comparison with the corresponding licensed vaccines in animal models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862236/ https://www.ncbi.nlm.nih.gov/pubmed/36680685 http://dx.doi.org/10.1007/s11596-022-2652-y |
work_keys_str_mv | AT huangfang optimizationoftheprocessforpreparingbivalentpolysaccharideconjugatestodevelopmultivalentconjugatevaccinesagainststreptococcuspneumoniaeorneisseriameningitidisandcomparisonwiththecorrespondinglicensedvaccinesinanimalmodels AT jingxiaobing optimizationoftheprocessforpreparingbivalentpolysaccharideconjugatestodevelopmultivalentconjugatevaccinesagainststreptococcuspneumoniaeorneisseriameningitidisandcomparisonwiththecorrespondinglicensedvaccinesinanimalmodels AT liyinbo optimizationoftheprocessforpreparingbivalentpolysaccharideconjugatestodevelopmultivalentconjugatevaccinesagainststreptococcuspneumoniaeorneisseriameningitidisandcomparisonwiththecorrespondinglicensedvaccinesinanimalmodels AT wangqian optimizationoftheprocessforpreparingbivalentpolysaccharideconjugatestodevelopmultivalentconjugatevaccinesagainststreptococcuspneumoniaeorneisseriameningitidisandcomparisonwiththecorrespondinglicensedvaccinesinanimalmodels AT liusili optimizationoftheprocessforpreparingbivalentpolysaccharideconjugatestodevelopmultivalentconjugatevaccinesagainststreptococcuspneumoniaeorneisseriameningitidisandcomparisonwiththecorrespondinglicensedvaccinesinanimalmodels AT yangzhirong optimizationoftheprocessforpreparingbivalentpolysaccharideconjugatestodevelopmultivalentconjugatevaccinesagainststreptococcuspneumoniaeorneisseriameningitidisandcomparisonwiththecorrespondinglicensedvaccinesinanimalmodels AT fengsu optimizationoftheprocessforpreparingbivalentpolysaccharideconjugatestodevelopmultivalentconjugatevaccinesagainststreptococcuspneumoniaeorneisseriameningitidisandcomparisonwiththecorrespondinglicensedvaccinesinanimalmodels |